Abstract
AST (aspartate aminotransferase; GOT, glutamate oxalacetate transaminase) and ALT (alanine aminotransferase; GPT, glutamate pyruvate transaminase) are sensitive indicators to monitor the liver function under drugs treatment or with acute viral hepatitis. The elevated AST and ALT values in the blood sample indicate liver damage or injury. The determination of urea is the most widely used for the evaluation of kidney function. This protocol is for the quantitative determination of AST, ALT and UREA/BUN in serum and plasma on Roche automated clinical chemistry analyzers. The principle is shown below:For AST: α-ketoglutarate + L-aspartate L-glutamate + oxaloacetate (AST catalyzes this equilibrium reaction) oxaloacetate + NADH + H+ L-malate + NAD+ (malate dehydrogenase catalyzes this equilibrium reaction) The rate of the photometrically determined NADH decrease is directly proportional to the rate of formation of oxaloacetate and thus the AST activity. The above reactions were carried out at 37 °C and measured at a wavelength of 340 nm.For ALT: α-ketoglutarate + L-alanine L-glutamate + pyruvate (ALT catalyzes this equilibrium reaction) Pyruvate + NADH + H+ L-lactate + NAD+ (lactate dehydrogenase catalyzes this equilibrium reaction) The rate of the photometrically determined NADH decrease is directly proportional to the rate of formation of pyruvate and thus the ALT activity. The above reactions were carried out at 37 °C and measured at a wavelength of 340 nm.For UREA/BUN: Urea + H2O → 2 NH4+ + CO2 (urea is hydrolyzed by urease) α-ketoglutarate + NH4+ + NADH → L-glutamate + NAD+ + H2O (the presence of GLDH yields glutamate and NAD+) The decrease in absorbance due to consumption of NADH is measured kinetically. The above reactions were carried out at 37 °C and measured at a wavelength of 340 nm.
Keywords: Liver Function, AST, ALT, Urea/BUN
Materials and Reagents
Equipment
Procedure
Notes
Recipes
Acknowledgments
This protocol was adapted from the previously published paper, Sher et al. (2009). This work was supported by Grants from NRPGM in DOH97-TD-G-111-041 (to M-C Hung) and DOH97-TD-111-TM003 (to L-Y. Li). YP Sher was also supported by a postdoctoral fellowship award from the National Health Research Institutes, Taiwan (PD9602).
References
If you have any questions/comments about this protocol, you are highly recommended to post here. We will invite the authors of this protocol as well as some of its users to address your questions/comments. To make it easier for them to help you, you are encouraged to post your data including images for the troubleshooting.